Mesa Laboratories PE Ratio 2010-2024 | MLAB
Current and historical p/e ratio for Mesa Laboratories (MLAB) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Mesa Laboratories PE ratio as of May 23, 2025 is 13.05.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Mesa Laboratories PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-05-23 | 109.85 | 0.00 | |
2024-12-31 | 131.71 | $-46.26 | 0.00 |
2024-09-30 | 129.53 | $-45.56 | 0.00 |
2024-06-30 | 86.45 | $-46.42 | 0.00 |
2024-03-31 | 109.16 | $-47.14 | 0.00 |
2023-12-31 | 104.07 | $0.17 | 612.20 |
2023-09-30 | 104.18 | $-0.14 | 0.00 |
2023-06-30 | 127.27 | $0.33 | 385.66 |
2023-03-31 | 172.85 | $0.16 | 1080.29 |
2022-12-31 | 164.26 | $-0.29 | 0.00 |
2022-09-30 | 139.05 | $-0.76 | 0.00 |
2022-06-30 | 201.18 | $-0.30 | 0.00 |
2022-03-31 | 251.24 | $0.35 | 717.82 |
2021-12-31 | 323.20 | $1.43 | 226.01 |
2021-09-30 | 297.70 | $0.93 | 320.11 |
2021-06-30 | 266.83 | $0.74 | 360.58 |
2021-03-31 | 239.45 | $0.58 | 412.85 |
2020-12-31 | 281.71 | $-0.53 | 0.00 |
2020-09-30 | 250.23 | $-0.70 | 0.00 |
2020-06-30 | 212.80 | $-0.50 | 0.00 |
2020-03-31 | 221.79 | $0.41 | 540.94 |
2019-12-31 | 244.50 | $1.12 | 218.30 |
2019-09-30 | 232.94 | $2.39 | 97.46 |
2019-06-30 | 239.20 | $1.93 | 123.94 |
2019-03-31 | 225.51 | $1.86 | 121.24 |
2018-12-31 | 203.74 | $2.60 | 78.36 |
2018-09-30 | 181.34 | $-0.54 | 0.00 |
2018-06-30 | 206.05 | $-0.19 | 0.00 |
2018-03-31 | 144.76 | $-0.86 | 0.00 |
2017-12-31 | 121.07 | $-1.00 | 0.00 |
2017-09-30 | 145.27 | $2.77 | 52.44 |
2017-06-30 | 139.26 | $2.79 | 49.91 |
2017-03-31 | 119.11 | $2.91 | 40.93 |
2016-12-31 | 119.00 | $3.03 | 39.27 |
2016-09-30 | 110.74 | $2.82 | 39.27 |
2016-06-30 | 118.93 | $2.67 | 44.54 |
2016-03-31 | 93.01 | $2.79 | 33.34 |
2015-12-31 | 95.88 | $2.34 | 40.97 |
2015-09-30 | 107.19 | $2.37 | 45.23 |
2015-06-30 | 85.41 | $2.74 | 31.17 |
2015-03-31 | 69.24 | $2.62 | 26.43 |
2014-12-31 | 73.99 | $2.96 | 25.00 |
2014-09-30 | 55.18 | $2.78 | 19.85 |
2014-06-30 | 80.01 | $2.48 | 32.26 |
2014-03-31 | 85.84 | $2.49 | 34.47 |
2013-12-31 | 74.61 | $2.25 | 33.16 |
2013-09-30 | 64.07 | $2.21 | 28.99 |
2013-06-30 | 51.19 | $2.31 | 22.16 |
2013-03-31 | 49.78 | $2.38 | 20.91 |
2012-12-31 | 47.14 | $2.29 | 20.58 |
2012-09-30 | 45.38 | $2.42 | 18.75 |
2012-06-30 | 43.49 | $2.37 | 18.35 |
2012-03-31 | 46.01 | $2.27 | 20.27 |
2011-12-31 | 38.56 | $2.29 | 16.84 |
2011-09-30 | 32.78 | $2.10 | 15.61 |
2011-06-30 | 29.20 | $1.94 | 15.05 |
2011-03-31 | 26.51 | $1.85 | 14.33 |
2010-12-31 | 27.51 | $1.61 | 17.08 |
2010-09-30 | 20.99 | $1.58 | 13.29 |
2010-06-30 | 21.83 | $1.53 | 14.27 |
2010-03-31 | 23.46 | $1.44 | 16.29 |
2009-12-31 | 23.25 | $1.41 | 16.49 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.597B | $0.216B |
MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $193.381B | 84.70 |
Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
Alcon (ALC) | Switzerland | $42.675B | 28.84 |
IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
DexCom (DXCM) | United States | $33.137B | 51.22 |
STERIS (STE) | Ireland | $23.875B | 26.33 |
IQVIA Holdings (IQV) | United States | $23.701B | 13.28 |
Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
Waters (WAT) | United States | $20.612B | 29.08 |
SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
Hologic (HOLX) | United States | $12.096B | 13.14 |
Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
Penumbra (PEN) | United States | $10.399B | 81.62 |
Masimo (MASI) | United States | $8.140B | 30.03 |
Globus Medical (GMED) | United States | $7.982B | 19.02 |
Glaukos (GKOS) | United States | $5.487B | 0.00 |
Teleflex (TFX) | United States | $5.337B | 8.81 |
TransMedics (TMDX) | United States | $4.203B | 91.36 |
Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
Veracyte (VCYT) | United States | $2.127B | 29.85 |
Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
Artivion (AORT) | United States | $1.222B | 114.44 |
Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
OPKO Health (OPK) | United States | $0.999B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
SiBone (SIBN) | United States | $0.783B | 0.00 |
IRadimed (IRMD) | United States | $0.650B | 32.96 |
RxSight (RXST) | United States | $0.637B | 0.00 |
Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
NeuroPace (NPCE) | United States | $0.580B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
AxoGen (AXGN) | United States | $0.504B | 0.00 |
Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
Neuronetics (STIM) | United States | $0.263B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
Inogen (INGN) | United States | $0.176B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
CVRx (CVRX) | United States | $0.174B | 0.00 |
908 Devices (MASS) | United States | $0.172B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
Accuray (ARAY) | United States | $0.162B | 0.00 |
LENSAR (LNSR) | United States | $0.160B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.123B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
InspireMD (NSPR) | Israel | $0.078B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
Hyperfine (HYPR) | United States | $0.042B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
Spectral AI (MDAI) | United States | $0.037B | 0.00 |
Envoy Medical (COCH) | United States | $0.035B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
DarioHealth (DRIO) | United States | $0.032B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.017B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.004B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |